Remodeling the Human Adult Stem Cell Niche for Regenerative Medicine Applications

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2017 Nov 2

PMID 29090011

Citations 11

Authors

Silvana Bardelli

Marco Moccetti

Affiliations

Soon will be listed here.

Abstract

The interactions between stem cells and their surrounding microenvironment are pivotal to determine tissue homeostasis and stem cell renewal or differentiation and regeneration . Ever since they were postulated in 1978, stem cell niches have been identified and characterized in many germline and adult tissues. Comprehensive studies over the last decades helped to clarify the critical components of stem cell niches that include cellular, extracellular, biochemical, molecular, and physical regulators. This knowledge has direct impact on their inherent regenerative potential. Clinical applications demand readily available cell sources that, under controlled conditions, provide a specific therapeutic function. Thus, translational medicine aims at optimizing or the various components and complex architecture of the niche to exploit its therapeutic potential. Accordingly, the objective is to recreate the natural niche microenvironment during cell therapy process development and closely comply with the requests of regulatory authorities. In this paper, we review the most recent advances of translational medicine approaches that target the adult stem cell natural niche microenvironment for regenerative medicine applications.

Citing Articles

The Complementary Roles of Neurological and Musculoskeletal Physical Therapy and Regenerative Medicine: A Comprehensive Review.

Mureed M, Sattar T, Batool S, Zahid A, Usman Khan H, Fatima A Medicina (Kaunas). 2024; 60(7).

PMID: 39064491 PMC: 11278673. DOI: 10.3390/medicina60071062.

Favorable culture conditions for spermatogonial propagation in human and non-human primate primary testicular cell cultures: a systematic review and meta-analysis.

van Maaren J, Alves L, van Wely M, van Pelt A, Mulder C Front Cell Dev Biol. 2024; 11:1330830.

PMID: 38259514 PMC: 10800969. DOI: 10.3389/fcell.2023.1330830.

Protective role of stem cells in POI: Current status and mechanism of action, a review article.

Sadeghi S, Mosaffa N, Huang B, Ramezani Tehrani F Heliyon. 2024; 10(1):e23271.

PMID: 38169739 PMC: 10758796. DOI: 10.1016/j.heliyon.2023.e23271.

Targeting the stem cell niche micro-environment as therapeutic strategies in aging.

Farahzadi R, Valipour B, Montazersaheb S, Fathi E Front Cell Dev Biol. 2023; 11:1162136.

PMID: 37274742 PMC: 10235764. DOI: 10.3389/fcell.2023.1162136.

Cardiovascular Regeneration via Stem Cells and Direct Reprogramming: A Review.

Lee C, Kim J, Cho H, Kim H Korean Circ J. 2022; 52(5):341-353.

PMID: 35502566 PMC: 9064703. DOI: 10.4070/kcj.2022.0005.

References

Lu L, Yaszemski M, Mikos A . Retinal pigment epithelium engineering using synthetic biodegradable polymers. Biomaterials. 2001; 22(24):3345-55. DOI: 10.1016/s0142-9612(01)00172-7. View

Jochems C, van der Valk J, Stafleu F, Baumans V . The use of fetal bovine serum: ethical or scientific problem?. Altern Lab Anim. 2002; 30(2):219-27. DOI: 10.1177/026119290203000208. View

Hartung T, Balls M, Bardouille C, Blanck O, Coecke S, Gstraunthaler G . Good Cell Culture Practice. ECVAM Good Cell Culture Practice Task Force Report 1. Altern Lab Anim. 2002; 30(4):407-14. DOI: 10.1177/026119290203000404. View

Prockop D, Gregory C, Spees J . One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A. 2003; 100 Suppl 1:11917-23. PMC: 304107. DOI: 10.1073/pnas.1834138100. View

van der Valk J, Mellor D, Brands R, Fischer R, Gruber F, Gstraunthaler G . The humane collection of fetal bovine serum and possibilities for serum-free cell and tissue culture. Toxicol In Vitro. 2003; 18(1):1-12. DOI: 10.1016/j.tiv.2003.08.009. View

Gstraunthaler G . Alternatives to the use of fetal bovine serum: serum-free cell culture. ALTEX. 2003; 20(4):275-81. View

Torchiana D . Polyethylene glycol based synthetic sealants: potential uses in cardiac surgery. J Card Surg. 2004; 18(6):504-6. DOI: 10.1046/j.0886-0440.2003.00305.x. View

Lutolf M, Hubbell J . Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005; 23(1):47-55. DOI: 10.1038/nbt1055. View

Csete M . Oxygen in the cultivation of stem cells. Ann N Y Acad Sci. 2005; 1049:1-8. DOI: 10.1196/annals.1334.001. View

10.

Gupta K, Rispin A, Stitzel K, Coecke S, Harbell J . Ensuring quality of in vitro alternative test methods: issues and answers. Regul Toxicol Pharmacol. 2005; 43(3):219-24. DOI: 10.1016/j.yrtph.2005.03.010. View

11.

Mallon B, Park K, Chen K, Hamilton R, McKay R . Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol. 2006; 38(7):1063-75. PMC: 3449300. DOI: 10.1016/j.biocel.2005.12.014. View

12.

Even-Ram S, Artym V, Yamada K . Matrix control of stem cell fate. Cell. 2006; 126(4):645-7. DOI: 10.1016/j.cell.2006.08.008. View

13.

Engler A, Sen S, Sweeney H, Discher D . Matrix elasticity directs stem cell lineage specification. Cell. 2006; 126(4):677-89. DOI: 10.1016/j.cell.2006.06.044. View

14.

Shetty P, Bharucha K, Tanavde V . Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells. Cell Biol Int. 2007; 31(3):293-8. DOI: 10.1016/j.cellbi.2006.11.010. View

15.

Adams G, Martin R, Alley I, Chabner K, Cohen K, Calvi L . Therapeutic targeting of a stem cell niche. Nat Biotechnol. 2007; 25(2):238-43. DOI: 10.1038/nbt1281. View

16.

Lange C, Cakiroglu F, Spiess A, Cappallo-Obermann H, Dierlamm J, Zander A . Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol. 2007; 213(1):18-26. DOI: 10.1002/jcp.21081. View

17.

King J, Miller W . Bioreactor development for stem cell expansion and controlled differentiation. Curr Opin Chem Biol. 2007; 11(4):394-8. PMC: 2038982. DOI: 10.1016/j.cbpa.2007.05.034. View

18.

Adams G, Scadden D . A niche opportunity for stem cell therapeutics. Gene Ther. 2007; 15(2):96-9. DOI: 10.1038/sj.gt.3303063. View

19.

Laflamme M, Zbinden S, Epstein S, Murry C . Cell-based therapy for myocardial ischemia and infarction: pathophysiological mechanisms. Annu Rev Pathol. 2007; 2:307-39. DOI: 10.1146/annurev.pathol.2.010506.092038. View

20.

Jones D, Wagers A . No place like home: anatomy and function of the stem cell niche. Nat Rev Mol Cell Biol. 2007; 9(1):11-21. DOI: 10.1038/nrm2319. View